CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype

International Journal of Neuropsychopharmacology

Volumn 13, Issue 4, 2010, Pages 499-513

  Busquet, Perrine ^a   Khoi Nguyen, Ngoc ^a   Schmid, Eduard ^a   Tanimoto, Naoyuki ^b   Seeliger, Mathias W ^b   Ben Yosef, Tamar ^c   Mizuno, Fengxia ^d   Akopian, Abram ^d   Striessnig, Jrg ^a   Singewald, Nicolas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CaV1.3 1 subunits; Deafness; Depression; L type Ca2+ channels; Retinal function

Indexed keywords

CLAUDIN 14; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; CACNA1D PROTEIN, MOUSE; CALCIUM CHANNEL L TYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; ELECTRORETINOGRAPHY; FORCED SWIMMING TEST; HEARING IMPAIRMENT; HYPERTHERMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MORPHOLOGY; MOUSE; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; RETINA; TRANQUILIZING ACTIVITY; VISION; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; HYPERTHERMIC THERAPY; MAZE TEST; MOTOR ACTIVITY; MOUSE MUTANT; SYNAPSE; TONIC IMMOBILITY; ULTRASTRUCTURE;

ANIMALS; ANXIETY; CALCIUM CHANNELS, L-TYPE; DEAFNESS; DEPRESSION; DISEASE MODELS, ANIMAL; HYPERTHERMIA, INDUCED; IMMOBILITY RESPONSE, TONIC; MALE; MAZE LEARNING; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PHENOTYPE; RETINA; SYNAPSES;

EID: 77953542962     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709990368     Document Type: Article

References (71)

1. Anagnostopoulos AV (2002). A compendium of mouse knockouts with inner ear defects. Trends in Genetics 18, 499.
2. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005). Cost of disorders of the brain in Europe. European Journal of Neurology 12 (Suppl. 1), 1-27.
3. Barnes S, Kelly ME (2002). Calcium channels at the photoreceptor synapse. Advances in Experimental Medicine and Biology 514, 465-476.
4. Basile J (2004). The role of existing and newer calcium channel blockers in the treatment of hypertension. Journal of Clinical Hypertension (Greenwich) 6, 621-629; quiz 630-631.
5. Ben-Yosef T, Belyantseva IA, Saunders TL, Hughes ED, et al. (2003). Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Human Molecular Genetics 12, 2049-2061.
6. Blanchard DC, Blanchard RJ, Tom P, Rodgers RJ (1990). Diazepam changes risk assessment in an anxiety/defense test battery. Psychopharmacology (Berlin) 101, 511-518.
7. Brandstatter JH, Fletcher EL, Garner CC, Gundelfinger ED, Wassle H (1999). Differential expression of the presynaptic cytomatrix protein bassoon among ribbon synapses in the mammalian retina. European Journal of Neuroscience 11, 3683-3693.
8. 2+ channel isoforms in the extinction of conditioned fear. Learning & Memory 15, 378-386.
9. Carobrez AP, Bertoglio LJ (2005). Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neuroscience & Biobehavioral Reviews 29, 1193-1205.
10. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005). International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacological Reviews 57, 411-425.
11. Chan CS, Guzman JN, Ilijic E, Mercer JN, et al. (2007). 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447, 1081-1086.
12. Chang B, Heckenlively JR, Bayley PR, Brecha NC, et al. (2006). The nob2 mouse, a null mutation in Cacna1f: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Visual Neuroscience 23, 11-24.
13. Clark NC, Nagano N, Kuenzi FM, Jarolimek W, et al. (2003). Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels. Neuroscience 120, 435-442.
14. Cristofanilli M, Mizuno F, Akopian A (2007). Disruption of actin cytoskeleton causes internalization of Ca(v)1.3 (alpha 1D) L-type calcium channels in salamander retinal neurons. Molecular Vision 13, 1496-1507.
15. Cryan JF, Mombereau C (2004). In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Molecular Psychiatry 9, 326-357.
16. Cryan JF, Mombereau C, Vassout A (2005). The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neuroscience & Biobehavioral Reviews 29, 571-625.
17. Deisseroth K, Mermelstein PG, Xia H, Tsien RW (2003). Signaling from synapse to nucleus: the logic behind the mechanisms. Current Opinion in Neurobiology 13, 354-365.
18. Doering CJ, Peloquin JB, McRory JE (2007). The Ca(v)1.4 calcium channel: more than meets the eye. Channels 1, 3-10.
19. El Ganouni S, Tazi A, Hakkou F (1998). Potential serotonergic interactions with the anxiolytic-like effects of calcium channel antagonists. Pharmacology Biochemistry & Behavior 60, 365-369.
20. File SE (2001). Factors controlling measures of anxiety and responses to novelty in the mouse. Behavioural Brain Research 125, 151-157.
21. Gerlai R, Adams B, Fitch T, Chaney S, Baez M (2002). Performance deficits of mGluR8 knockout mice in learning tasks: the effects of null mutation and the background genotype. Neuropharmacology 43, 235-249.
22. Harro J (2006). CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies. Amino Acids 31, 215-230.
23. Hell JW, Westenbroek RE, Warner C, Ahlijanian MK, et al. (1993). Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. Journal of Cell Biology 123, 949-962.
24. 2+ channels: contribution of Ca(V)1.3 and Ca(V)1.2 isoforms. Neuroscience 139, 1005-1015.
25. Holtzheimer PER, Nemeroff CB (2006). Emerging treatments for depression. Expert Opinion in Pharmacotherapy 7, 2323-2339.
26. Kaesermann HP (1986). Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action. Psychopharmacology (Berlin) 89, 31-37.
27. Kamphuis W, Hendriksen H (1998). Expression patterns of voltage-dependent calcium channel alpha 1 subunits (alpha 1A-alpha 1E) mRNA in rat retina. Brain Research. Molecular Brain Research 55, 209-220.
28. Klein E, Steinberg SA, Weiss SR, Matthews DM, Uhde TW (1988). The relationship between genetic deafness and fear-related behaviors in nervous pointer dogs. Physiology & Behavior 43, 307-312.
29. Ko ML, Liu Y, Dryer SE, Ko GY (2007). The expression of L-type voltage-gated calcium channels in retinal photoreceptors is under circadian control. Journal of Neurochemistry 103, 784-792.
30. Kvam MH, Loeb M, Tambs K (2007). Mental health in deaf adults: symptoms of anxiety and depression among hearing and deaf individuals. Journal of Deaf Studies and Deaf Education 12, 1-7.
31. Lamberty Y, Gower AJ (1996). Arm width and brightness modulation of spontaneous behaviour of two strains of mice tested in the elevated plus-maze. Physiology & Behavior 59, 439-444.
32. Lister RG (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92, 180-185.
33. Ludwig A, Flockerzi V, Hofmann F (1997). Regional expression and cellular localization of the alpha1 and beta subunit of high voltage-activated calcium channels in rat brain. Journal of Neuroscience 17, 1339-1349.
34. Mansergh F, Orton NC, Vessey JP, Lalonde MR, et al. (2005). Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synaptic transmission and cellular organization in mouse retina. Human Molecular Genetics 14, 3035-3046.
35. 2+ channel antagonists with Vogel-type conflict test in rats. European Journal of Pharmacology 264, 107-110.
36. Mayorga AJ, Lucki I (2001). Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology (Berlin) 155, 110-112.
37. McRory JE, Hamid J, Doering CJ, Garcia E, et al. (2004). The CACNA1F gene encodes an L-type calcium channel with unique biophysical properties and tissue distribution. Journal of Neuroscience 24, 1707-1718.
38. Millan MJ (2006). Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacology & Therapeutics 110, 135-370.
39. 2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. Journal of Neuroscience 25, 9883-9892.
40. Morgans CW (1999). Calcium channel heterogeneity among cone photoreceptors in the tree shrew retina. European Journal of Neuroscience 11, 2989-2993.
41. Morgans CW, Bayley PR, Oesch NW, Ren G, et al. (2005). Photoreceptor calcium channels: insight from night blindness. Visual Neuroscience 22, 561-568.
42. Morgans CW, El Far O, Berntson A, Wassle H, Taylor WR (1998). Calcium extrusion from mammalian photoreceptor terminals. Journal of Neuroscience 18, 2467-2474.
43. Moser PC (1989). An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology (Berlin) 99, 48-53.
44. 2+ channels is dependent on a Shank-binding domain. Journal of Neuroscience 25, 1050-1062.
45. Painsipp E, Wultsch T, Edelsbrunner ME, Tasan RO, et al. (2008). Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes, Brain and Behavior 7, 532-542.
46. Pellow S, Chopin P, File SE, Briley M (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 14, 149-167.
47. Petit-Demouliere B, Chenu F, Bourin M (2005). Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berlin) 177, 245-255.
48. Pillay NS, Stein DJ (2007). Emerging anxiolytics. Expert Opinion on Emerging Drugs 12, 541-554.
49. 2+ channels. Cell 102, 89-97.
50. Rabin RA, Wolfe BB, Dibner MD, Zahniser NR, et al. (1980). Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. Journal of Pharmacology and Experimental Therapeutics 213, 491-496.
51. Rodgers RJ, Cole JC (1994). Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test. European Journal of Pharmacology 261, 321-325.
52. Rodgers RJ, Cole JC, Cobain MR, Daly P, et al. (1992). Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behavioural Pharmacology 3, 621-634.
53. Schmitz F, Konigstorfer A, Sudhof TC (2000). RIBEYE, a component of synaptic ribbons: a protein's journey through evolution provides insight into synaptic ribbon function. Neuron 28, 857-872.
54. Seeliger MW, Grimm C, Stahlberg F, Friedburg C, et al. (2001). New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nature Genetics 29, 70-74.
55. Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994). Behavioural and pharmacological characterisation of the elevated 'zero-maze' as an animal model of anxiety. Psychopharmacology (Berlin) 116, 56-64.
56. Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H (2004). Magnesium-deficient diet alters depression-and anxiety-related behavior in mice-influence of desipramine and Hypericum perforatum extract. Neuropharmacology 47, 1189-1197.
57. 2+ channels. Journal of Clinical Investigation 113, 1430-1439.
58. Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, et al. (2008). Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Molecular Pharmacology 75, 407-414.
59. Soubrie P (1989). Neuropsychological profiles of calcium antagonists. Fundamental & Clinical Pharmacology 3 (Suppl.), 71s-78s.
60. Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berlin) 85, 367-370.
61. Striessnig J (2007). C-terminal tailoring of L-type calcium channel function. Journal of Physiology 585, 643-644.
62. 2+ channels with gene Knockout models. Channels 2, 1-19.
63. Taragano FE, Bagnatti P, Allegri RF (2005). A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of 'vascular depression'. International Psychogeriatrics 17, 487-498.
64. Trullas R, Skolnick P (1993). Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology (Berlin) 111, 323-331.
65. Tschenett A, Singewald N, Carli M, Balducci C, et al. (2003). Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. European Journal of Neuroscience 18, 143-148.
66. Van der Heyden JA, Zethof TJ, Olivier B (1997). Stress-induced hyperthermia in singly housed mice. Physiology & Behavior 62, 463-470.
67. Vetter DE, Li C, Zhao L, Contarino A, et al. (2002). Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nature Genetics 31, 363-369.
68. Waltereit R, Mannhardt S, Nescholta S, Maser-Gluth C, Bartsch D (2008). Selective and protracted effect of nifedipine on fear memory extinction correlates with induced stress response. Learning & Memory 15, 348-356.
69. Xu HP, Zhao JW, Yang XL (2002). Expression of voltage-dependent calcium channel subunits in the rat retina. Neuroscience Letters 329, 297-300.
70. Yamada K, Santo-Yamada Y, Wada E, Wada K (2002). Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice. Molecular Psychiatry 7, 113-117.
71. Zhang H, Fu Y, Altier C, Platzer J, et al. (2006). Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. European Journal of Neuroscience 23, 2297-2310.